KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer
出版年份 2021 全文链接
标题
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-09
DOI
10.1007/s10549-021-06325-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
- (2020) Seung-Su Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression
- (2020) Liyun Luo et al. Cell Death & Disease
- The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
- (2019) Theodoros Rampias et al. EMBO REPORTS
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
- (2019) Nicole A. McNeer et al. LEUKEMIA
- Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
- (2019) Eliana MC Tacconi et al. EMBO Molecular Medicine
- Genomic characterization of metastatic breast cancers
- (2019) François Bertucci et al. NATURE
- Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
- (2019) Shengfeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- A practical guide for mutational signature analysis in hematological malignancies
- (2019) Francesco Maura et al. Nature Communications
- Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer
- (2019) Xiaoqing Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
- (2019) Khushnuma Wahabi et al. BMC CANCER
- Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
- (2019) Li Liu et al. CLINICAL CANCER RESEARCH
- Structural basis of nucleosome recognition and modification by MLL methyltransferases
- (2019) Han Xue et al. NATURE
- Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer
- (2019) Carmen Criscitiello et al. CURRENT OPINION IN ONCOLOGY
- Nuclear Genomic Instability and Aging
- (2018) Laura J. Niedernhofer et al. Annual Review of Biochemistry
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer
- (2018) Maliha T. Munir et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
- (2018) Lu Wang et al. NATURE MEDICINE
- KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
- (2018) Kinisha Gala et al. ONCOGENE
- Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
- (2018) Barbara Pasculli et al. SEMINARS IN CANCER BIOLOGY
- Cancer epigenetics: Moving forward
- (2018) Angela Nebbioso et al. PLoS Genetics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress in adjuvant systemic therapy for breast cancer
- (2018) Noam F. Pondé et al. Nature Reviews Clinical Oncology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2018) Yijie Sun et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Functions and mechanisms of epigenetic inheritance in animals
- (2018) Ksenia Skvortsova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
- (2018) Elen Kristine Höglander et al. Genome Medicine
- Generation of an arrayed CRISPR-Cas9 library targeting epigenetic regulators: from high-content screens to in vivo assays
- (2017) Tristan Henser-Brownhill et al. Epigenetics
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma
- (2016) J. B. N. Dawkins et al. CANCER RESEARCH
- Structural basis for activity regulation of MLL family methyltransferases
- (2016) Yanjing Li et al. NATURE
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3
- (2016) Kamila M. Jozwik et al. Cell Reports
- Gene-Expression-Based Predictors for Breast Cancer
- (2015) Arjun Gupta et al. ANNALS OF SURGICAL ONCOLOGY
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- GOplot: an R package for visually combining expression data with functional analysis: Fig. 1.
- (2015) Wencke Walter et al. BIOINFORMATICS
- A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
- (2015) Vakaramoko Diaby et al. BREAST CANCER RESEARCH AND TREATMENT
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
- (2015) Yoshinaga Okugawa et al. GASTROENTEROLOGY
- Breast cancer
- (2015) Chris Woolston NATURE
- Epigenetic regulation of ageing: linking environmental inputs to genomic stability
- (2015) Bérénice A. Benayoun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Somatic mutation in cancer and normal cells
- (2015) I. Martincorena et al. SCIENCE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Genetic landscape of esophageal squamous cell carcinoma
- (2014) Yi-Bo Gao et al. NATURE GENETICS
- Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features
- (2014) Davor Lessel et al. NATURE GENETICS
- Mechanisms underlying mutational signatures in human cancers
- (2014) Thomas Helleday et al. NATURE REVIEWS GENETICS
- Exploiting epigenetic vulnerabilities for cancer therapeutics
- (2014) Barbara Mair et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Epigenetic mechanisms of breast cancer: an update of the current knowledge
- (2014) Seher Karsli-Ceppioglu et al. Epigenomics
- Epigenetic regulation in cancer progression
- (2014) Eva Baxter et al. Cell and Bioscience
- Epigenetic Research in Cancer Epidemiology: Trends, Opportunities, and Challenges
- (2013) M. Verma et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Breast cancer statistics, 2011
- (2011) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4
- (2011) Khairul I Ansari et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Challenges, controversies, breakthroughs
- (2010) Lisa Hutchinson Nature Reviews Clinical Oncology
- Chemotherapy for breast cancer (Review)
- (2010) Hassan ONCOLOGY REPORTS
- Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
- (2009) S. Germano et al. CURRENT CANCER DRUG TARGETS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now